Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
15.9%
% of WDNA's 91 holdings also in CNCR
19.4%
% of CNCR's 72 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
BLUEPRINT MEDICINES CORP. | 2.6% | 1.7% | 1.7% |
|
GERON CORP | 2.5% | 1.4% | 1.4% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.7% | 1.3% | 1.3% |
|
MERCK & CO. INC. | 1.2% | 1.4% | 1.2% |
 |
GENMAB A/S SPONSORED ADR | 1.1% | 1.2% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to CNCR
|
TWIST BIOSCIENCE CORP. | 4.3% |
|
NOVOZYMES A/S-B SHARES | 2.7% |
|
AGIOS PHARMACEUTICALS INC | 2.4% |
|
NATERA INC | 2.2% |
|
VERICEL CORPORATION | 2.1% |
|
ELI LILLY & CO | 2.1% |
|
SAREPTA THERAPEUTICS INC | 1.7% |
|
BRIDGEBIO PHARMA, INC. | 1.6% |
|
VERTEX PHARMACEUTICALS INC | 1.6% |
|
UNITED THERAPEUTICS CORP | 1.5% |
WDNA Underweight Relative to CNCR
|
RECURSION PHARMACEUTICALS, INC CLASS | -3.3% |
|
MONTE ROSA THERAPEUTICS, INC. | -2.1% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -2.1% |
|
EXELIXIS INC | -2.0% |
|
JANUX THERAPEUTICS, INC. | -1.9% |
|
REPLIMUNE GROUP, INC. | -1.9% |
|
XENCOR INC | -1.8% |
|
MERSANA THERAPEUTICS, INC. | -1.7% |
|
ARCELLX, INC. | -1.7% |
|
SPRINGWORKS THERAPEUTICS, INC. | -1.7% |